了解Pax5在抗多塞素的神经内分泌类型前列腺癌的发展中的作用
Sreyashi Bhattacharya1, Hannah L Harris2, Ridwan Islam1
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
Cell death & disease
|August 25, 2024
概括
治疗诱导的神经内分泌样前列腺癌 (t-NEPC) 发展出对ARSI治疗的耐药性. 在t-NEPC中,Pax5激活驱动神经元特征和分类物耐药性,这表明Pax5是恢复敏感性的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 雄激素受体信号抑制剂 (ARSI) 疗法可以诱导激进的治疗诱导的神经内分泌类前列腺癌 (t-NEPC).
- t-NEPC对标准的分类物化学疗法表现出耐药性,并且存活率很低.
- 目前对t-NEPC的治疗方法的疗效有限,系统性毒性显著.
研究的目的:
- 确定驱动t-NEPC中神经元特征的关键转录因子.
- 调查这些因素在税种耐药性中的作用.
- 探索在t-NEPC中克服治疗耐药性的潜在治疗目标.
主要方法:
- 在NE类细胞系模型上使用ATAC-Seq,ChIP-seq和RNA-seq.
- 分析了转录活跃和丰富的NE类癌症特异基因.
- 进行了途径分析,以了解基因表达调节和功能角色.
主要成果:
- 在t-NEPC中确定Pax5为神经元基因表达的关键转录因子.
- 证明Pax5调节涉及神经元通信和粘附的通路.
- 显示Pax5枯竭通过破坏细胞通信和生长因子信号传递,使NE类细胞对多塞素敏感.
- 揭示了表观遗传修饰,包括基甲基化,通过Pbx1结合促进Pax5表达.
结论:
- ARSI治疗诱导了表观遗传变化,导致Pax5在t-NEPC中的激活.
- 帕克斯5激活通过启用类似NE的癌症特征来促进对标素的抗性.
- 针对Pax5通路提供了一种有希望的策略,以重新使t-NEPC对税疗法敏感.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.0K
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K